Gene · 4485
Papers4,329
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 4,329
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tumor-Suppressive and Oncogenic Roles of microRNA-149-5p in Human Cancers. | Int J Mol Sci | 2022 | 36142734 | PubTator, text mining | PubMed |
| Crosstalk between Hypoxia and Extracellular Matrix in the Tumor Microenvironment in Breast Cancer. | Genes (Basel) | 2022 | 36140753 | PubTator, text mining | PubMed |
| Application of Micro-Western Array for Identifying Different Serum Protein Expression Profile among Healthy Control, Alzheimer's Disease Patients and Patients' Adult Children. | Brain Sci | 2022 | 36138870 | PubTator, text mining | PubMed |
| High Gas-Phase Methanesulfonic Acid Production in the OH-Initiated Oxidation of Dimethyl Sulfide at Low Temperatures. | Environ Sci Technol | 2022 | 36137236 | PubTator, text mining | PubMed |
| NHR-23 and SPE-44 regulate distinct sets of genes during Caenorhabditis elegans spermatogenesis. | G3 (Bethesda) | 2022 | 36135804 | PubTator, text mining | PubMed |
| Complementary and alternative therapies in skin cancer a literature review of biologically active compounds. | Dermatol Ther | 2022 | 36124923 | PubTator, text mining | PubMed |
| lncRNAs: Key Regulators of Signaling Pathways in Tumor Glycolysis. | Dis Markers | 2022 | 36124026 | PubTator, text mining | PubMed |
| CAF-derived exosomal WEE2-AS1 facilitates colorectal cancer progression via promoting degradation of MOB1A to inhibit the Hippo pathway. | Cell Death Dis | 2022 | 36123327 | PubTator, text mining | PubMed |
| Identification and validation of the role of c-Myc in head and neck squamous cell carcinoma. | Front Oncol | 2022 | 36119473 | PubTator, text mining | PubMed |
| MicroRNA-mediated regulation of key signaling pathways in hepatocellular carcinoma: A mechanistic insight. | Front Genet | 2022 | 36118880 | PubTator, text mining | PubMed |
| A Review on Inflammatory Bowel Diseases: Recent Molecular Pathophysiology Advances. | Biologics | 2022 | 36118798 | PubTator, text mining | PubMed |
| NEK2 inactivates the Hippo pathway to advance the proliferation of cervical cancer cells by cooperating with STRIPAK complexes. | Cancer Lett | 2022 | 36115593 | PubTator, text mining | PubMed |
| Recent advances of the mammalian target of rapamycin signaling in mesenchymal stem cells. | Front Genet | 2022 | 36110206 | PubTator, text mining | PubMed |
| Temporal dynamics of Plasmodium falciparum population in Metehara, east-central Ethiopia. | Malar J | 2022 | 36109748 | PubTator, text mining | PubMed |
| miR-22-3p as a potential biomarker for coronary artery disease based on integrated bioinformatics analysis. | Front Genet | 2022 | 36105099 | PubTator, text mining | PubMed |
| Exploration of fetal growth restriction induced by vitamin D deficiency in rats via Hippo-YAP signaling pathway. | Placenta | 2022 | 36103800 | PubTator, text mining | PubMed |
| Tyrosine kinase receptor RON activates MAPK/RSK/CREB signal pathway to enhance CXCR4 expression and promote cell migration and invasion in bladder cancer. | Aging (Albany NY) | 2022 | 36103228 | PubTator, text mining | PubMed |
| Therapeutic effect of modified zengye decoction on primary Sjogren's syndrome and its effect on plasma exosomal proteins. | Front Pharmacol | 2022 | 36091838 | PubTator, text mining | PubMed |
| mTORC2 Is the Major Second Layer Kinase Negatively Regulating FOXO3 Activity. | Molecules | 2022 | 36080182 | PubTator, text mining | PubMed |
| Hypoxia Triggers TAZ Phosphorylation in Basal A Triple Negative Breast Cancer Cells. | Int J Mol Sci | 2022 | 36077517 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4485/papers?page=38